Add this topic to your myFT Digest for news straight to your inbox
GlaxoSmithKline, Merck and Sanofi are left playing catch-up to upstarts with new technology
Executive vice-president Robert Davis will take helm at US drugmaker
Pharma group’s publicity-shy chief has made a remarkable intervention over George Floyd’s killing
Business school professors study leaders who take a position on controversial topics
Industry titans are willing to take an unusually public stand
Oil group makes new governance concession after large shareholders demanded access
Union leaders and steel industry representative resign over Charlottesville
There is a moral — and practical — case for chief executives to dump the US president
US state pension fund wants greater access to oil group’s board
International Edition